Journal: Frontiers in Pharmacology
Article Title: Molecular mechanisms of the anchang group prescription in treating radiation enteritis: network pharmacology analysis and experimental evidence
doi: 10.3389/fphar.2025.1524925
Figure Lengend Snippet: ACZF improves colitis via pathways involving PI3K/AKT signaling. (a) Representative immunoblots and the relative expression levels of AKT, p-AKT, PI3K, and p-PI3K in colon tissues from different treatment groups; (b) ZO-1and claudin-1 expression in the colon tissues of the colitis mice was detected by Western blot; (c) Colonic cytokine levels of TNF-α, IL-1β, IL-6, and IL-10. Data represent means ± SD (n = 4). **p < 0.01 vs. Control group; ##p < 0.01 vs. Model group; $ p < 0.05 vs. ACZF group; $$ p < 0.01 vs. ACZF group.
Article Snippet: The PI3K activator YS-49 (No. HY-15477) was obtained from MedChem Express.
Techniques: Western Blot, Expressing, Control